Form 4: Colgate-Palmolive CEO Noel Wallace Reports Stock Transaction for Tax Obligations

Sentiment:

SEC Form 4 Filing


Colgate-Palmolive's CEO, Noel Wallace, disposed of 954 shares of common stock to cover Medicare and income tax liabilities related to previously granted restricted stock units.

Summary

  • Noel Wallace, the Chairman, President, and CEO of Colgate-Palmolive, reported a transaction involving the disposal of 954 shares of common stock on December 3, 2024.
  • The shares were sold at a price of $94.61 per share.
  • This transaction was conducted to cover Medicare and income tax liabilities associated with previously granted restricted stock units.
  • The reporting person continues to hold the restricted stock units originally granted, less the amount of this required tax withholding.
  • Following the transaction, Mr. Wallace directly owns 269,735 shares of common stock.
  • He also indirectly owns 52,561 shares through the Issuer's 401(k) Plan Trustee, 52,000 shares through a Spouse Trust, and 335 shares through another Trust.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction for tax purposes, which is neutral to slightly positive as it indicates the executive is receiving compensation in the form of stock.

Industry Context

This is a routine filing related to executive compensation and tax obligations, and is common for publicly traded companies.

Comparison to Industry Standards

  • Executive stock transactions are a common occurrence in publicly traded companies, particularly around vesting periods for restricted stock units.
  • The sale of shares to cover tax liabilities is a standard practice and does not indicate any unusual activity.
  • Other companies such as Procter & Gamble and Unilever also have similar filings related to executive stock transactions.

Stakeholder Impact

  • The transaction has a minimal impact on shareholders as it is a routine sale of shares for tax purposes.
  • The transaction does not impact employees, customers, suppliers, or creditors.

Key Dates

DateDescription
12/03/2024Date of the stock transaction.
12/05/2024Date of signature on the Form 4 filing.

Keywords

Colgate-Palmolive, CEO, Noel Wallace, stock transaction, Form 4, insider trading, restricted stock units, tax liabilities

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.